Substitution of methotrexate for cyclophosphamide in Wegener granulomatosis: A 12-year single-practice experience

Medicine

Volumn 86, Issue 5, 2007, Pages 269-277

  Villa Forte, Alexandra ^a   Clark, Tiffany M ^a   Gomes, Marcelo ^a   Carey, John ^a   Mascha, Edward ^a   Karafa, Matthew T ^a   Roberson, Gerald ^a   Langford, Carol A ^a   Hoffman, Gary S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; METHOTREXATE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG SUBSTITUTION; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; LABORATORY TEST; LUNG HEMORRHAGE; LYMPHOCYTOPENIA; MALE; MEDICAL RESEARCH; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REMISSION; SCORING SYSTEM; TREATMENT OUTCOME; VASCULITIS; WEGENER GRANULOMATOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CYCLOPHOSPHAMIDE; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIERS ESTIMATE; MALE; METHOTREXATE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS;

EID: 34548681195     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e3181568ec0     Document Type: Article

References (15)

1. Cronstein BN, Naime D, Ostad E. The anti-inflammatory mechanism of methotrexate. J Clin Invest. 1993;92:2675-2682.
2. De Groot K, Rasmussen N, Bacon PA, Cohen-Tervaert JW, Feighery C, Gregorini G, Gross WL, Luqmani R, Jayne DRW (European Vasculitis Study Group). Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2005;52:2461-2469.
3. De Groot K, Reinhold-Keller E, Tatsis E, Paulsen J, Heller M, Nolle B, Gross WL. Therapy for maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Arthritis Rheum. 1996;39:2052-2061.
4. Fauci AS, Dale DC, Wolff SM. Cyclophosphamide and lymphocyte subpopulations in Wegener's granulomatosis. Arthritis Rheum. 1974;17:355-361.
5. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983;98:76-85.
6. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116:488-498.
7. Hoffman GS, Leavitt RY, Kerr GS, Fauci AS. The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum. 1992;35:1322-1329.
8. Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniene J, Ekstrand A, Gaskin G, Gregorini G, De Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C; European Vasculitis Study Group. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349:36-44.
9. Langford CA, Talar-Williams C, Barron KS, Sneller MC. A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance. Arthritis Rheum. 1999;42:2666-2673.
10. Langford CA, Talar-Williams C, Sneller MC. Use of methotrexate and glucocorticoids in the treatment of Wegener's granulomatosis. Longterm renal outcome in patients with glomerulonephritis. Arthritis Rheum. 2000;43:1836-1840.
11. Reinhold-Keller E, Beuge N, Latza U, De Groot K, Nolle B, Heller M, Gross WL. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum. 2000;43:1021-1032.
12. Sneller MC, Hoffman GS, Talar-Williams C, Kerr GS, Hallahan CW, Fauci AS. An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. Arthritis Rheum. 1995;38:608-613.
13. Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB, Specks U, Allen NB, Davis JC, Spiera RF, Calabrese LH, Wigley FM, Maiden N, Valente RM, Niles JL, Fye KH, McCune JW, St Clair EW, Luqmani RA; International Network for the Study of the Systemic Vasculitides (INSSYS). A disease specific activity index for Wegener's granulomatosis. Arthritis Rheum. 2001;44:912-920.
14. Wegener's Granulomatosis Etanercept Research Group (WGET). Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med. 2005;352:351-361.
15. Zhu L, Cupps TR, Whalen G, Fauci AS. Selective effects of cyclophosphamide therapy on activation, proliferation and differentiation of B cells. J Clin Invest. 1987;79:1082-1090.